| Jonathan Matthew Soh, MD | |
|
505 Beahan Rd, Rochester, NY 14624-3403 | |
| (716) 755-6647 | |
| (716) 755-6648 |
| Full Name | Jonathan Matthew Soh |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 8 Years |
| Location | 505 Beahan Rd, Rochester, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104271840 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 290940 (New York) | Secondary |
| 207ND0101X | Dermatology - Mohs-micrographic Surgery | 290940 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Rochester General Hospital | Rochester, NY | Hospital |
| Entity Name | Rochester General Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356412712 PECOS PAC ID: 0244149474 Enrollment ID: O20031121000644 |
News Archive
Applied NeuroSolutions, Inc.(www.AppliedNeuroSolutions.com), a biotechnology company focused on the development of products for the early diagnosis and treatment of Alzheimer's disease ("AD"), today confirmed, as previously disclosed in July 2009, that it has achieved sufficient analytical sensitivity to detect tau in serum patient samples.
For patients with the most common type of noninvasive breast cancer, routine testing for estrogen and progesterone receptors in tissue taken at the first "needle" biopsy is both unnecessary and wasteful, according to results of a study led by Johns Hopkins pathologists.
Defects in the body's regulatory T cells (T reg cells) cause inflammation and autoimmune disease by altering the type of bacteria living in the gut, researchers from The University of Texas Health Science Center at Houston have discovered.
The dangers of heat were today highlighted by the Chief Medical Officer Sir Liam Donaldson with the publication of an updated heatwave plan and new public information leaflets.
Researchers at Moffitt Cancer Center have completed a phase II clinical trial to determine the safety and efficacy of dasatinib for patients with higher-risk myelodysplastic syndromes, chronic myelomonocytic leukemia, or acute myeloid leukemia resulting from MDS and have failed treatment with azanucleosides.
› Verified 3 days ago
| Entity Name | Western New York Medical Practice Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063790608 PECOS PAC ID: 3870767791 Enrollment ID: O20111110000598 |
News Archive
Applied NeuroSolutions, Inc.(www.AppliedNeuroSolutions.com), a biotechnology company focused on the development of products for the early diagnosis and treatment of Alzheimer's disease ("AD"), today confirmed, as previously disclosed in July 2009, that it has achieved sufficient analytical sensitivity to detect tau in serum patient samples.
For patients with the most common type of noninvasive breast cancer, routine testing for estrogen and progesterone receptors in tissue taken at the first "needle" biopsy is both unnecessary and wasteful, according to results of a study led by Johns Hopkins pathologists.
Defects in the body's regulatory T cells (T reg cells) cause inflammation and autoimmune disease by altering the type of bacteria living in the gut, researchers from The University of Texas Health Science Center at Houston have discovered.
The dangers of heat were today highlighted by the Chief Medical Officer Sir Liam Donaldson with the publication of an updated heatwave plan and new public information leaflets.
Researchers at Moffitt Cancer Center have completed a phase II clinical trial to determine the safety and efficacy of dasatinib for patients with higher-risk myelodysplastic syndromes, chronic myelomonocytic leukemia, or acute myeloid leukemia resulting from MDS and have failed treatment with azanucleosides.
› Verified 3 days ago
| Entity Name | Soh Skin & Surgery Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760154090 PECOS PAC ID: 2567860240 Enrollment ID: O20211011001258 |
News Archive
Applied NeuroSolutions, Inc.(www.AppliedNeuroSolutions.com), a biotechnology company focused on the development of products for the early diagnosis and treatment of Alzheimer's disease ("AD"), today confirmed, as previously disclosed in July 2009, that it has achieved sufficient analytical sensitivity to detect tau in serum patient samples.
For patients with the most common type of noninvasive breast cancer, routine testing for estrogen and progesterone receptors in tissue taken at the first "needle" biopsy is both unnecessary and wasteful, according to results of a study led by Johns Hopkins pathologists.
Defects in the body's regulatory T cells (T reg cells) cause inflammation and autoimmune disease by altering the type of bacteria living in the gut, researchers from The University of Texas Health Science Center at Houston have discovered.
The dangers of heat were today highlighted by the Chief Medical Officer Sir Liam Donaldson with the publication of an updated heatwave plan and new public information leaflets.
Researchers at Moffitt Cancer Center have completed a phase II clinical trial to determine the safety and efficacy of dasatinib for patients with higher-risk myelodysplastic syndromes, chronic myelomonocytic leukemia, or acute myeloid leukemia resulting from MDS and have failed treatment with azanucleosides.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jonathan Matthew Soh, MD 8770 Transit Rd Ste 3, East Amherst, NY 14051-1786 Ph: (716) 755-6647 | Jonathan Matthew Soh, MD 505 Beahan Rd, Rochester, NY 14624-3403 Ph: (716) 755-6647 |
News Archive
Applied NeuroSolutions, Inc.(www.AppliedNeuroSolutions.com), a biotechnology company focused on the development of products for the early diagnosis and treatment of Alzheimer's disease ("AD"), today confirmed, as previously disclosed in July 2009, that it has achieved sufficient analytical sensitivity to detect tau in serum patient samples.
For patients with the most common type of noninvasive breast cancer, routine testing for estrogen and progesterone receptors in tissue taken at the first "needle" biopsy is both unnecessary and wasteful, according to results of a study led by Johns Hopkins pathologists.
Defects in the body's regulatory T cells (T reg cells) cause inflammation and autoimmune disease by altering the type of bacteria living in the gut, researchers from The University of Texas Health Science Center at Houston have discovered.
The dangers of heat were today highlighted by the Chief Medical Officer Sir Liam Donaldson with the publication of an updated heatwave plan and new public information leaflets.
Researchers at Moffitt Cancer Center have completed a phase II clinical trial to determine the safety and efficacy of dasatinib for patients with higher-risk myelodysplastic syndromes, chronic myelomonocytic leukemia, or acute myeloid leukemia resulting from MDS and have failed treatment with azanucleosides.
› Verified 3 days ago
Dr. Yana Veyberman Ignatovich, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 120 Erie Canal Dr, Rochester, NY 14626 Phone: 585-719-9600 | |
Dr. Walter S Brooks, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 730 Weiland Rd, Rochester, NY 14626 Phone: 585-719-9600 Fax: 585-719-9872 | |
Dr. Leena Mehta, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 2211 Lyell Ave, Rochester, NY 14606 Phone: 585-429-5555 Fax: 585-429-6581 | |
Dr. Christopher Brent Yelverton, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 10 Hagen Dr Ste 300, Rochester, NY 14625 Phone: 585-922-9770 Fax: 585-922-9733 | |
Dr. Lesley C Loss, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 100 White Spruce Blvd, Rochester, NY 14623 Phone: 585-272-0700 Fax: 585-272-8356 | |
Allison L Holm, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 30 N Union St, Suite 105, Rochester, NY 14607 Phone: 585-232-8940 Fax: 585-232-8687 |